Frank Sullivan

Aug 8, 2024 | innovations.bmj.com | Frank Sullivan |Peter Donnelly |Magdalena Staworko |Oscar Khawar

AbstractObjective To describe recommendations applicable to new diagnostic and screening tests brought to market in the UK as of 01 June 2023; and extract agreements, disagreements and gaps. Design Extant regulations, recommendations and guidelines for new diagnostic and screening tests applicable to new products placed in the UK market as of 01 June 2023. Non-English and references not applicable to new tests seeking market access in the UK on 01 June 2023 were excluded.

Feb 19, 2024 | bmj.com | Margaret McCartney |Frank Sullivan |Kamran Abbasi

Margaret McCartney, senior lecturer1, Frank Sullivan, professor of primary care medicine1, Kamran Abbasi, editor in chief21St Andrews University, St Andrews, UK2The BMJ, London, UKCorrespondence to: M McCartney mm494{at}st-andrews.ac.ukA broken system must be fixed in the public interestThe UK drug industry has much to be proud of, but the interests of industry, patients, and a cost effective NHS are not always aligned—and may be fundamentally opposed.